These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7168013)

  • 81. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
    Rudavsky AZ; Freeman LM
    J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
    [No Abstract]   [Full Text] [Related]  

  • 82. Recurrence of prostate adenocarcinoma presenting with multiple myeloma simulating skeletal metastases of prostate adenocarcinoma.
    Huang E; Teh BS; Saleem A; Butler EB
    Urology; 2002 Dec; 60(6):1111. PubMed ID: 12475684
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Preoperative US-guided hook-needle insertion in recurrent lymph nodes of papillary thyroid cancer: a help for the surgeon.
    Duprez R; Lebas P; Marc OS; Mongeois E; Emy P; Michenet P
    Eur J Radiol; 2010 Jan; 73(1):40-2. PubMed ID: 19036543
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma.
    Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V
    Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Measurement of thyroglobulin mRNA in peripheral blood as an adjunctive test for monitoring thyroid cancer.
    Grammatopoulos D; Elliott Y; Smith SC; Brown I; Grieve RJ; Hillhouse EW; Levine MA; Ringel MD
    Mol Pathol; 2003 Jun; 56(3):162-6. PubMed ID: 12782763
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Bone metastases from thyroid carcinoma: a histopathologic study with clinical correlates.
    Tickoo SK; Pittas AG; Adler M; Fazzari M; Larson SM; Robbins RJ; Rosai J
    Arch Pathol Lab Med; 2000 Oct; 124(10):1440-7. PubMed ID: 11035572
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
    Bruwer G; Heyns CF; Allen FJ
    Eur Urol; 1999; 35(3):223-7. PubMed ID: 10072624
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Thyroglobulin in benign and malignant thyroid disease.
    Gerfo PL; Colacchio T; Colacchio D; Feind C
    JAMA; 1979 Mar; 241(9):923-4. PubMed ID: 762873
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A Clear Cell Variant of Papillary Thyroid Microcarcinoma With Lung, Bone, and Soft Tissue Metastases.
    Yazici B; Ertan Y; Oral A; Akgün A
    Clin Nucl Med; 2015 Nov; 40(11):885-7. PubMed ID: 26018685
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma.
    David A; Blotta A; Rossi R; Zatelli MC; Bondanelli M; Roti E; Braverman LE; Busutti L; degli Uberti EC
    Thyroid; 2005 Mar; 15(3):267-73. PubMed ID: 15785246
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Undetectable serum prostate-specific antigen associated with metastatic prostate cancer: a case report and review of the literature.
    Safa AA; Reese DM; Carter DM; Phillipson J; Smith R; Dougherty S
    Am J Clin Oncol; 1998 Aug; 21(4):323-6. PubMed ID: 9708626
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.
    Robbins RJ; Srivastava S; Shaha A; Ghossein R; Larson SM; Fleisher M; Tuttle RM
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6010-6. PubMed ID: 15579752
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Serum thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) in thyroid cancer.
    Sundram FX; Sethi VK; Aw SE
    Ann Acad Med Singap; 1986 Oct; 15(4):535-8. PubMed ID: 3566173
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Serum thyroglobulin in thyroid neoplasms].
    Mimura T; Ishikawa N; Hasegawa M; Manabe Y; Momotani S
    Horumon To Rinsho; 1983 Aug; 31(8):731-5. PubMed ID: 6627707
    [No Abstract]   [Full Text] [Related]  

  • 96. 99mTc-sestamibi and 131I whole-body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma.
    Ng DC; Sundram FX; Sin AE
    J Nucl Med; 2000 Apr; 41(4):631-5. PubMed ID: 10768563
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Thyroglobulin as a tumor marker in thyroid adenocarcinoma--its effectiveness and problems in monitoring cancer activities].
    Aoki N; Nagata I; DeGroot LJ
    Nihon Gan Chiryo Gakkai Shi; 1983 Apr; 18(3):673-81. PubMed ID: 6619633
    [No Abstract]   [Full Text] [Related]  

  • 98. Thyroglobulin may be undetectable in the serum of patients with metastatic disease secondary to differentiated thyroid carcinoma. Follow-up of differentiated thyroid carcinoma.
    Grant S; Luttrell B; Reeve T; Wiseman J; Wilmshurst E; Stiel J; Donohoe D; Cooper R; Bridgman M
    Cancer; 1984 Oct; 54(8):1625-8. PubMed ID: 6478402
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue.
    Schlumberger M; Fragu P; Parmentier C; Tubiana M
    Acta Endocrinol (Copenh); 1981 Oct; 98(2):215-21. PubMed ID: 7293653
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Serum levels and thyroid tissue expression of CA50 and CA 19-9 in patients with thyroid tumor.
    Matsuura B; Taniguchi Y; Nakanishi K; Murakami T; Ohta Y; Katoh R; Tajiri J; Noguchi S
    Endocrinol Jpn; 1991 Oct; 38(5):565-71. PubMed ID: 1843277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.